Dr. George highlights Time to Progression Regimen in CLL Management
Dr. George Follows, UK
Dr. George Follows, a Consultant Haematologist at Cambridge University Hospitals and Professor of Haematology at Anglia Ruskin Medical School, discusses the critical evaluation of BTK inhibitors (BTKis) for the treatment of CLL and discussed its overall outcomes in CLL and relapsed CLL, as well as toxicity considerations.
Explore more videos
The CLL Management in Clinic
Dr. Hani Osman, UAE
Review on Fixed Duration Regimen in CLL Management
Dr. Mahmoud Marashi, UAE
Translating Data Into Practice
Dr. Ihab El-Hemaidi, KSA